VIATRIS INC. O.N. (VIA)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 16.56 |
|---|---|
| 52-week range | 8.68 – 16.69 |
| Return, 1 month / 3 months | +10.6% / +9.9% |
| Return, 1 year / 3 years | +89.7% / +114.3% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 27.8% |
| Worst drawdown (1 year) | -17.0% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Viatris is a pharmaceutical company that makes and sells generic and branded medicines. Its portfolio includes off-patent prescription drugs, complex generics and biosimilars, along with consumer health products sold in pharmacies and through health systems. The company serves patients, prescribers and healthcare payers across many countries, with manufacturing and commercial operations spread around the world. Viatris is based in the United States, in Pennsylvania.
The shares are listed on the XETRA Stock Exchange in Germany under the code VIA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
VIATRIS INC. O.N. (VIA) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 16.56 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 44 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 89.7% and over the last three months it rose 9.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.6% | ||
| From 52-week high | -0.2% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.9% | ||
| 6-month return | 34.3% | ||
| 12-month return, skipping the last month | 71.5% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.0% | ||
| Liquidity | 31 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +10.6% |
| 3 months | +9.9% |
| 6 months | +34.3% |
| 1 year | +89.7% |
| 3 years | +114.3% |
| 5 years | +68.2% |
Signals
| 50-day / 200-day average | 14.98 / 13.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.35 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Aug 2026 | USD 0.1067 |
| 22 May 2026 | USD 0.1067 |
| 9 Mar 2026 | USD 0.1067 |
| 24 Nov 2025 | USD 0.1067 |
| 22 Aug 2025 | USD 0.1067 |
| 23 May 2025 | USD 0.1067 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.